ATTENSION DEFICIT/HYPERACTIVITY DISORDER (ADHD)- signs and symptoms, Diagnosis, latest management

Background: Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity and impulsivity. It affects millions of children, adults globally every year. ICD-11 guidelines state that ADHD onset begins before 12-years age and often persists in the adulthood. This is a review article which focuses mainly on ADHD symptoms and differentiates between child and adulthood symptoms. The 3 main symptoms of ADHD are inattentiveness, hyperactive-impulse symptoms and combined symptoms. Knowing the different symptoms in both the adults and children help in understanding the treatment options also. Managing ADHD is needed to improve the quality of life of effected patients, this article provides a brief therapeutic management and Simtriyo is the recently approved new drug for ADHD treatment in adults and pediatrics. This new drug approval helps to increase the treatment options. Although, not well-known , but the use of EndeavorRX, a video game for treating ADHD can also improve the symptoms. Managing ADHD: it includes both pharmacological and non-pharmacological treatments. Pharmacotherapy includes stimulants such as methylphenidate, amphetamines and non -stimulants such as atomoxetine, viloxazine, alpha-2 agonist (clonidine, guanfacine). Recently Centanafadine (Simtriyo) has been approved by FDA. Centanafadine is a norepinephrine, dopamine, serotonin reuptake inhibitors which helps in decreasing the symptoms. Non- pharmacological approaches are neurofeedback, dietary supplements, behavioral therapy.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24414261
Primary Topic
Attention Deficit Hyperactivity Disorder
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

ATTENSION DEFICIT/HYPERACTIVITY DISORDER (ADHD)- signs and symptoms, Diagnosis, latest management

Anusha Rudroju, Km Grace, Keerthana Reddy Danam
Zenodo (CERN European Organization for Nuclear Research)
Attention Deficit Hyperactivity Disorder
article

ATTENSION DEFICIT/HYPERACTIVITY DISORDER (ADHD)- signs and symptoms, Diagnosis, latest management

Anusha Rudroju, Km Grace, Keerthana Reddy Danam
article en

Abstract

Background: Attention-Deficit/Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity and impulsivity. It affects millions of children, adults globally every year. ICD-11 guidelines state that ADHD onset begins before 12-years age and often persists in the adulthood. This is a review article which focuses mainly on ADHD symptoms and differentiates between child and adulthood symptoms. The 3 main symptoms of ADHD are inattentiveness, hyperactive-impulse symptoms and combined symptoms. Knowing the different symptoms in both the adults and children help in understanding the treatment options also. Managing ADHD is needed to improve the quality of life of effected patients, this article provides a brief therapeutic management and Simtriyo is the recently approved new drug for ADHD treatment in adults and pediatrics. This new drug approval helps to increase the treatment options. Although, not well-known , but the use of EndeavorRX, a video game for treating ADHD can also improve the symptoms. Managing ADHD: it includes both pharmacological and non-pharmacological treatments. Pharmacotherapy includes stimulants such as methylphenidate, amphetamines and non -stimulants such as atomoxetine, viloxazine, alpha-2 agonist (clonidine, guanfacine). Recently Centanafadine (Simtriyo) has been approved by FDA. Centanafadine is a norepinephrine, dopamine, serotonin reuptake inhibitors which helps in decreasing the symptoms. Non- pharmacological approaches are neurofeedback, dietary supplements, behavioral therapy.

Zenodo (CERN European Organization for Nuclear Research)
G Pulla Reddy Dental College & Hospital (IN)
Attention Deficit Hyperactivity Disorder
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
ATTENSION DEFICIT/HYPERACTIVITY DISORDER (ADHD)- signs and symptoms, Diagnosis, latest management — Anusha Rudroju, Km Grace, et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS